151 related articles for article (PubMed ID: 21129770)
1. Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.
Karageorgi S; McGrath M; Lee IM; Buring J; Kraft P; De Vivo I
Gynecol Oncol; 2011 Apr; 121(1):54-8. PubMed ID: 21129770
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
Terry K; McGrath M; Lee IM; Buring J; De Vivo I
Gynecol Oncol; 2010 May; 117(2):255-9. PubMed ID: 20199803
[TBL] [Abstract][Full Text] [Related]
3. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
4. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.
Olson SH; Bandera EV; Orlow I
Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese women.
Hosono S; Ito H; Oze I; Higaki Y; Morita E; Takashima N; Suzuki S; Shimatani K; Mikami H; Ohnaka K; Ozaki E; Katsuura-Kamano S; Kubo M; Nagata C; Naito M; Hamajima N; Tanaka H;
Maturitas; 2015 Dec; 82(4):394-401. PubMed ID: 26323233
[TBL] [Abstract][Full Text] [Related]
6. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors.
Figueroa JD; Sakoda LC; Graubard BI; Chanock S; Rubertone MV; Erickson RL; McGlynn KA
Cancer Causes Control; 2008 Nov; 19(9):917-29. PubMed ID: 18415690
[TBL] [Abstract][Full Text] [Related]
8. Interaction of soy and 17beta-HSD1 gene polymorphisms in the risk of endometrial cancer.
Dai Q; Xu WH; Long JR; Courtney R; Xiang YB; Cai Q; Cheng J; Zheng W; Shu XO
Pharmacogenet Genomics; 2007 Feb; 17(2):161-7. PubMed ID: 17301695
[TBL] [Abstract][Full Text] [Related]
9. The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy.
Audet-Walsh É; Bellemare J; Lacombe L; Fradet Y; Fradet V; Douville P; Guillemette C; Lévesque É
Eur Urol; 2012 Jul; 62(1):88-96. PubMed ID: 22209174
[TBL] [Abstract][Full Text] [Related]
10. SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium.
Cheng YH; Imir A; Suzuki T; Fenkci V; Yilmaz B; Sasano H; Bulun SE
Biol Reprod; 2006 Oct; 75(4):605-14. PubMed ID: 16807381
[TBL] [Abstract][Full Text] [Related]
11. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
Brinton LA; Trabert B; Anderson GL; Falk RT; Felix AS; Fuhrman BJ; Gass ML; Kuller LH; Pfeiffer RM; Rohan TE; Strickler HD; Xu X; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1081-9. PubMed ID: 27197275
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.
Cheng YH; Yin P; Xue Q; Yilmaz B; Dawson MI; Bulun SE
J Clin Endocrinol Metab; 2008 May; 93(5):1915-23. PubMed ID: 18270252
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.
Sinreih M; Hevir N; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):210-7. PubMed ID: 23200943
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 17beta-hydroxysteroid dehydrogenase type 2, type 4 and type 5 by calcitriol, LXR agonist and 5alpha-dihydrotestosterone in human prostate cancer cells.
Wang JH; Tuohimaa P
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):100-5. PubMed ID: 17627817
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
Cancer Epidemiol; 2010 Jun; 34(3):328-37. PubMed ID: 20381444
[TBL] [Abstract][Full Text] [Related]
17. Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.
Konings GF; Cornel KM; Xanthoulea S; Delvoux B; Skowron MA; Kooreman L; Koskimies P; Krakstad C; Salvesen HB; van Kuijk K; Schrooders YJ; Vooijs M; Groot AJ; Bongers MY; Kruitwagen RF; ; Romano A
J Pathol; 2018 Feb; 244(2):203-214. PubMed ID: 29144553
[TBL] [Abstract][Full Text] [Related]
18. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer.
Rizner TL; Smuc T; Rupreht R; Sinkovec J; Penning TM
Mol Cell Endocrinol; 2006 Mar; 248(1-2):126-35. PubMed ID: 16338060
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
20. Epistasis between the HSD17B4 and TG polymorphisms is associated with premature ovarian failure.
Pyun JA; Kim S; Cha DH; Ko JJ; Kwack K
Fertil Steril; 2012 Apr; 97(4):968-73. PubMed ID: 22265031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
